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ril 30, 2013.he aim of the present study was to elucidate right ventricular (RV) function and structure in patients with chronic
obstructive pulmonary disease (COPD) without pulmonary hypertension (PH).Background There is little knowledge of RV function and remodeling in COPD without PH.Methods Thirty-four controls and 98 patients with COPD were included. The study patients were divided into 2 groups by right
heart catheterization: no PH (mean pulmonary artery pressure [mPAP] <25 mm Hg) and PH (mPAP 25 mm Hg).
The echocardiographic tissue Doppler imaging variables of RV isovolumic acceleration, peak systolic strain, and RV
myocardial performance index were measured at the basal free wall, and RV wall thickness and RV internal
dimension were measured in the RV outﬂow tract.Results The increases in RV wall thickness and RV dimension were more evident when comparing controls with the no PH
group (3.5  0.5 mm to 5.5  1.0 mm [p < 0.01] and 1.5 cm  0.2 to 2.0  0.5 cm [p < 0.01]) than comparing
the no PH group with the PH group (5.5  1.0 mm to 6.6  1.1 mm [p < 0.01] and 2.0 cm  0.5 to 2.1  0.3 cm
[p ¼ NS]), respectively. Similarly, RV isovolumic acceleration, performance index, and strain deteriorated signiﬁcantly
when comparing controls with the no PH group and comparing the no PH group with the PH group (p< 0.01). Signiﬁcant
correlations were observed between mPAP and RV isovolumic acceleration, performance index, strain, and RV wall
thickness (p < 0.01). RV impairment and increased RV wall thickness and RV dimensions were present even at
slight elevations of mPAP (18  3 mm Hg) in the no PH group.Conclusions The present study showed that impaired RV systolic function, hypertrophy, and dilation were present even at a slight
increase of mPAP, which indicates an early impact on RV function and structure in patients with COPD. RV isovolumic
acceleration, performance index, and strain could detect subclinical disease and separate controls from those with no
PH. (J Am Coll Cardiol 2013;62:1103–11) ª 2013 by the American College of Cardiology FoundationThe development of right heart failure in patients with
chronic obstructive pulmonary disease (COPD) is linked to
worse outcomes with an increased risk of hospital read-
missions and mortality (1,2). Thus, noninvasive imaging
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13; revised manuscript received April 23, 2013,ventricular (RV) function are crucial in a clinical setting.
Several studies have investigated RV function in patients
with COPD who have pulmonary hypertension (PH) (3–5).
However, little information is available on RV function in
patients with COPD who do not have PH.
COPD is associated with structural and mechanical
changes in the pulmonary vascular bed that increase RV
afterload. Pulmonary vascular remodeling occurs not only inSee page 1112patients with advanced COPD but also in patients with mild
disease and even in smokers with normal lung function (6,7).
This narrowing and stiffening process occurs in both the
proximal and distal pulmonary arteries and results in increased
Table 1
Demographics, LV
Without PH Comp
Age (yrs)
Female (n)
Body mass index (kg/m2)
Body surface area (m2)
Heart rate (beats/min)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
N-terminal pro-hormone of brain nat
LV ejection fraction (%)
LV transmitral early diastolic velocit
LV transmitral early diastolic velocit
Left atrial volume (ml/m2)
Smoking habits (n)x
Pack-years of smoking
FEV1 % predicted
FVC % predicted
FEV1/FVC (%)
Diffusion capacity for carbon monox
Residual volume % predicted
Inspiratory capacity/total lung capac
6-min walk distance (m)
Values are mean  SD or n. *Signiﬁcantly
COPD ¼ chronic obstructive pulmonary
hypertension.
Abbreviations
and Acronyms
CI = conﬁdence interval
COPD = chronic obstructive
pulmonary disease
GOLD = Global Initiative for
Chronic Obstructive Lung
Disease
LV = left ventricular
mPAP = mean pulmonary
artery pressure
PA = pulmonary artery
PH = pulmonary
hypertension
PVR = pulmonary vascular
resistance
PWP = pulmonary wedge
pressure
RV = right ventricular
TDI = tissue Doppler imaging
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1104pulmonary vascular resistance
(PVR) and reduced pulmonary
artery (PA) compliance (8).
Although invasive hemodynamic
measurements of RV function still
remain the gold standard, echocar-
diography is the standard clinical
method to assess RV function.
However, echocardiographic as-
sessment of RV function is often
difﬁcult using conventional me-
thods because of the complexity
of the anatomy of the right ven-
tricle. Novel techniques such as
3-dimensional evaluation of RV
ejection fraction, tissue Doppler
imaging (TDI) velocities, and strain
have emerged and enable identi-
ﬁcation of impaired RV function
at an earlier stage.
Thus, the present study soughtto identify subclinical RV systolic dysfunction at rest,
before hemodynamic decompensation, by applying modern
echocardiographic imaging in a cohort of patients with
stable COPD. We hypothesized that remodeling of the
pulmonary arteries, increased steady state, and pulsatile RV
afterload would have a secondary impact on RV geometry
and function in patients with COPD who had a meanSystolic/Diastolic Functional Indices, and
ared With Healthy Controls
Variables
riuretic peptide (pmol/l)z
y/late diastolic velocity ratio
y/septal mitral annular early diastolic tissue velocity
ide of the lungs % predicted
ity
different from controls. ySigniﬁcantly different from no PH. z
disease; FEV1 ¼ forced expiratory volume in 1 s; FVC ¼ forpulmonary artery pressure (mPAP) below the current gui-
deline deﬁnition of PH.Methods
Study patients. Ninety-eight outpatients with stable
COPD of varying severity and free of overt cardiovascular
disease were consecutively included in this study from 2006
to 2010 (Table 1). The diagnosis of COPD was based on
a history of cigarette smoking of at least 10 pack-years and
spirometric irreversible airway obstruction according to
current guidelines (9). Spirometry, diffusion capacity for
carbon monoxide, and measurement of arterial blood gases
were performed according to guidelines. Patients were cla-
ssiﬁed according to Global Initiative for Chronic Ob-
structive Lung Disease (GOLD) criteria (9).
White patients who were 40 to 75 years of age with spiro-
metric conﬁrmed COPD in GOLD stages II to IV were
included. They had to be free of exacerbations of COPD for
the 2 months before inclusion in the study. A small number of
these patients were treated with supplemental oxygen,
administered as long-term treatment with oxygen in 8 patients
and as ambulatory oxygen support in 4 patients. All partici-
pants underwent preinclusion screening, including resting
electrocardiogram and a dynamic exercise test on a cycle
ergometer. Patients with left ventricular (LV) disease, treated
arterial hypertension with blood pressure >160/90 mm Hg,
arrhythmias (including atrial ﬁbrillation), other acute orPulmonary Function in Patients With COPD With and
Healthy Controls
(n ¼ 34)
No PH
(n ¼ 72)
PH
(n ¼ 26) p Value
63  7 64  6 62  8 NS
19 34 15 NS
25  3 24  5 25  6 NS
1.9  0.2 1.8  0.2 1.8  0.3 NS
66  11 87  14* 95  18*y <0.01
120  17 139  22* 140  18* <0.01
76  12 69  12* 68  13* <0.01
N/A 9.3 (2.1–40.4) 9.9 (1.4–68.7) NS
61  5 57  4* 58  5* <0.01
1.07  0.29 1.04  0.25 1.03  0.26 NS
7.7  1.5 8.6  2.1 10.3  2.2*y <0.01
21  4 24  5* 21  5 <0.01
2/13/19 23/49/0* 8/18/0* <0.01
8  9 41  19* 39  20* <0.01
98  10 46  15* 32  12*y <0.01
105  11 76  20* 61  16*y <0.01
76  4 49  11* 43  13*y <0.01
100  15 57  19* 36  20*y <0.01
119  16 192  59 241  60*y <0.01
0.44  0.08 0.32  0.11 0.23  0.12*y <0.01
N/A 489  113 343  149y <0.01
Geometric mean (95% conﬁdence interval). xCurrent, former, and never smokers, respectively.
ced vital capacity; LV ¼ left ventricular ejection fraction; N/A ¼ not measured; PH ¼ pulmonary
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1105chronic pulmonary disease, malignancy, metabolic conditions,
hyperthyroidism, systemic inﬂammatory diseases, and renal
failure were excluded. Patients treated with beta-blockers,
warfarin, or clopidogrel were also excluded. A detailed study
design and COPD baseline characteristics of the entire study
group were reported previously (10).
The patients withCOPDwere compared with a group of 34
controls with a similar age and sex distribution and determined
to be healthy based on clinical, spirometric, biochemical, and
imaging investigations (Table 1). The healthy volunteers were
recruited from the hospital staff and their relatives. The study
complied with the Declaration of Helsinki and was approved
by the local research ethics committee. Written informed
consent was obtained from all subjects.
Doppler echocardiography. All study patients underwent
a comprehensive Doppler echocardiographic examination
during breath hold in end-expiratory phase within 2 h of right
heart catheterization using a Vivid7 and stored for ofﬂine
analyses (GE Vingmed Ultrasound, Horten, Norway). The
recordings were performed from left parasternal long- and
short-axis and apical 4-chamber views, adjusted to acquire the
RV-focused view. TDI was performed using a high frame rate
(median of 175 [range of 143 to 268] frame rate per second).
The RV free wall basal segment and tricuspid annulus were
considered the most reliable imaging regions of the right
ventricle, and a region of interest was placed at these 2 sites to
measure peak TDI velocities and peak systolic longitudinal
strain. LV systolic function was estimated by LV ejection
fraction (11), and LV diastolic function was estimated by
transmitral pulsed Doppler early velocity/early TDI at the
septal annular mitral leaﬂet and left atrial volume, respectively
(12). All results were the average of 3 measurements, and
analyses were performed without knowledge of clinical status.
RV size and wall thickness. RV end-diastolic area and RV
end-systolic area were assessed by manual planimetry and
divided by body surface area. Basal, midcavity, and longi-
tudinal dimensions were obtained at end diastole and
indexed for body surface area. RV outﬂow tract proximal
dimensions were measured in end diastole and end systole by
M-mode imaging. RV wall thickness was obtained from the
short-axis window by either M-mode imaging or 2-
dimensional echocardiography in end diastole. RV hyper-
trophy was deﬁned by an RV anterior wall thickness 0.55/
0.60 cm in female/male subjects, respectively (13).
RV systolic function. Maximal longitudinal tricuspid
annular displacement was measured, and RV fractional area
change and RV outﬂow tract fractional shortening were
derived (14). RV myocardial performance index was esti-
mated using the pulsed tissue Doppler method with the
region of interest (5 mm) at the lateral tricuspid annulus.
Myocardial acceleration during isovolumic contraction was
obtained by color-coded tissue Doppler with the region of
interest (6/4 mm) at the RV free wall basal segment (15).
Real-time 3-dimensional echocardiography was used to
acquire full-volumetric datasets of the right ventricle from 4
electrocardiography-triggered subvolumes. Post-processinganalysis (TomTec Imaging Systems GmbH, Germany) was
performed with semiautomatic software with pre-deﬁned
RV views for endocardial contour delineation, permitting
measurement of RV end-diastolic and systolic volumes.
Hemodynamic measurements. Pressure transducers were
balanced against atmospheric pressure, and the zero reference
level for recording was 5 cm below the sternal angle (10). An
electrocardiogram and heart rate were recorded continuously,
and cardiac output was determined by thermodilution tech-
nique. All pressures, including mPAP, right atrial pressure,
pulmonary wedge pressure (PWP), and RV pressures, were
measured at end expiration. PVR was calculated as: (mPAP –
mean PWP)/cardiac output in Wood units. PA compliance
was calculated as RV stroke volume/pulse pressure in milliliters
per millimeters of mercury. Patients were categorized as having
PH if the mPAP was25 mmHg and as having no PH if the
mPAP was<25 mmHg (16). No PH was further divided into
an mPAP 20 mm Hg and an mPAP of 21 to 24 mm Hg.
Statistical analysis. Continuous variables are expressed as
mean  SD. For comparison of continuous data between
controls and COPD subgroups, analysis of variance with
Bonferroni correction was used. Independent-sample t test
was used for comparison of continuous hemodynamic data
between the COPD subgroups. The distribution of N-
terminal pro-hormone of brain natriuretic peptide was
skewed and hence log transformed before statistical analyses,
and results are reported in original scale in Table 1 as
geometric mean and 95% conﬁdence interval (CI). The
relationship of PVR and PA compliance was assessed by
regression analyses and curve ﬁttings (Sigma Plot version
12.0). Multivariate regression analyses were performed to
determine independent predictors of RV systolic function
indices. Variables for ﬁnal analyses were chosen by automatic
stepwise forward selection with p values set to 0.05.
Pearson correlation coefﬁcient was used to evaluate the
relationship between forced expiratory volume in 1 s percent
predicted and RV function and remodeling, and partial
correlation with adjustment for PaO2 was performed. A p
value <0.05 was considered statistically signiﬁcant. Repro-
ducibility data were tested by intraclass correlation coefﬁ-
cient in 10 random participants for 3 RV systolic indices,
one RV dimension, and wall thickness (J.M.H. and K.S.).
Results are presented as intraclass correlation with 95%
CI. The statistical analyses were performed using SPSS
version 20.Results
Patient characteristics. Table 1 shows the clinical data for
the healthy age- and sex-matched controls and the patients
with COPD. All participants had sinus rhythm. Type 2
diabetes mellitus and treated systemic hypertension were
present in 9% and 31% of subjects, respectively, equally
distributed in COPD subgroups. Seven patients were being
treated with single loop diuretics (20 to 40 mg/day) and 14
with hydrochlorothiazide (12.5 mg/day).
Table 2 Hemodynamic and Arterial Blood Gas Characteristics at Rest
Variable
No PH
(n ¼ 72)
PH
(n ¼ 26) p Value
Mean PAP (mm Hg) 18  3 29  4* <0.01
Systolic PAP (mm Hg) 28  5 41  8* <0.01
Diastolic PAP (mm Hg) 9  4 16  6* <0.01
Transpulmonary pressure gradient (mm Hg) 9  3 18  6* <0.01
Mean pulmonary wedge pressure (mm Hg) 8  4 11  3* <0.01
Mean right atrial pressure (mm Hg) 5  3 7  3* <0.01
Pulse pressure (mm Hg) 18  5 24  9* <0.01
RV end-diastolic pressure (mm Hg) 7  4 11  4* <0.01
RV systolic pressure (mm Hg) 32  6 42  7* <0.01
Pulmonary vascular resistance (Wood units) 2.0  0.9 3.3  0.9 <0.01
Pulmonary artery compliance (ml/mm Hg) 4.1  1.3 3.2  1.5 <0.01
Cardiac output (l/min) 5.2  1.0 5.6  1.2 0.054
Cardiac index (l/min/m2) 2.9  0.4 3.2  0.6* <0.01
Stroke volume indexed (ml/beats/m2) 39  7 38  6 0.413
Heart rate (beats/min) 74  12 84  13* <0.01
SvO2 (%) 72  3 67  7* <0.01
SaO2 (%) 96  2 92  5* <0.01
VO2 (ml/min)y 237  42 270  69* <0.01
PaO2 (kPa)z 9.8  1.2 8.2  1.6* <0.01
PaCO2 (kPa) 5.3  0.6 5.7  0.8* <0.05
HCO3
 (mmol/l) 25  2 27  4* <0.01
Values are mean  SD. *Signiﬁcantly different from no PH. yCalculated oxygen consumption ¼ CO rest  Hb  1.34 $ (SaO2 rest  SvO2 rest).
zStandard conversion: 1 kPa ¼ 7.501 mm Hg.
PAP ¼ pulmonary artery pressure; RV ¼ right ventricular; other abbreviations as in Table 1.
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1106Invasive hemodynamics. Table 2 summarizes the hemo-
dynamic and arterial blood gas data at rest for 98 patients
with COPD who underwent right heart catheterization.
The mean PVR in the no PH group was 2.0  0.9
Wood units. Fifty patients (69%) in the no PH group had
a PVR >1.5 Wood units, and the majority of patients with
GOLD stage II had an elevated PVR >1.5 Wood units at
rest (Fig. 1). Mean PA compliance in the no PH group was
4.1  1.3 ml/mm Hg. GOLD distribution showed a similar
pattern as observed for PVR; patients with GOLD stage II
had PA compliance ranging from below 2.0 to above 6.0
(Fig. 1). Figure 2 displays the hyperbolic relationship of
PVR and PA compliance (R2 ¼ 0.55; p < 0.0001). Invasive
measurements identifying RV dysfunction revealed signiﬁ-
cant differences between no PH and PH, but the values were
within the range of normal RV function in both groups
(Table 2). However, 14 (14%) of the 98 patients had a
cardiac index <2.5 l/min/m2, including 11 (15%) in the no
PH group and 3 (12%) in the PH group. None had
a severely reduced cardiac index below 2.0 l/min/m2.
RV systolic function. All 9 echocardiographic parameters
describing RV systolic function and the RV myocardial perfor-
mance index were signiﬁcantly impaired in both patients with no
PH and patients with PH compared with controls (Table 3).
RV myocardial performance index, RV isovolumic acceleration,
and strain showed the largest differences between controls and
those with no PH (Fig. 3). These 3 indices were still signiﬁcantly
impaired as compared with controls even in those with an
mPAP 20 mm Hg, which again showed no difference
compared with those with an mPAP of 21 to 24 mm Hg(Table 4). Signiﬁcant correlations (p < 0.01) were observed
between mPAP and RVmyocardial performance index (r¼ 0.5),
RV isovolumic acceleration (r ¼ 0.5), and strain (r ¼0.5).
RV myocardial performance index, RV isovolumic acceleration,
and strain correlated with forced expiratory volume in 1 s percent
predicted (r ¼ 0.36, r ¼ 0.34, and r ¼ 0.30 [p < 0.01 for
all], respectively), but not when adjusted for PaO2.
RV size and wall thickness. Parameters describing RV
geometry are presented in Table 3. RV wall thickness was
signiﬁcantly increased by 57% and 89% when comparing
controls with the no PH group and the PH group, respec-
tively (Table 3). Due to RV dilation in both groups, the RV
relative wall thickness increased less than then RV wall
thickness (15% and 33%, respectively). There was a similar
large and signiﬁcant increase in the 3 RV and the 2 RV
outﬂow tract dimensions when comparing the controls with
those in the no PH group, but it was clearly less when
comparing the no PH group with the PH group (Table 3,
Fig. 3). Table 4 shows that the increase in RV size and wall
thickness has already occurred in those patients with mPAP
below 20 mm Hg. RV wall thickness correlated well with
myocardial performance index (r ¼ 0.7; p < 0.01) and
mPAP with RV wall thickness and PaO2 (r ¼ 0.4 and
r ¼ 0.6; p < 0.01 for both), respectively. RV basal
dimension did not correlate with forced expiratory volume
percent predicted; RV wall thickness did (r ¼ 0.44;
p < 0.01), but with lower strength (r ¼ 0.30; p < 0.01)
when adjusted for PaO2. Forced expiratory volume percent
predicted explains only 8% of the variance in RV wall
thickness. A nonlinear relationship was shown between RV
Figure 1 Histograms of PVR and PAC
The ﬁgure displays the distribution of PVR and PAC at rest in an outpatient cohort
of 98 patients with COPD. Seventy-six patients (79%) of the entire cohort had PVR
above 1.5 Wood units (vertical dashed line in upper panel), corresponding to the
upper limit of the 95% conﬁdence interval for healthy controls (mean  1.96 SD)
(35). The majority of patients at GOLD stage II (68%) had a PVR >1.5 Wood units.
The lower limit of the 95% conﬁdence interval for PAC was 6.3 ml/mm Hg (vertical
dashed line in lower panel) (23). Ninety-four patients (96%) had a resting PA
compliance below 6.3 ml/mm Hg. COPD ¼ chronic obstructive pulmonary disease;
GOLD ¼ Global Initiative for Chronic Obstructive Lung Disease; PAC ¼ pulmonary
artery compliance; PVR ¼ pulmonary vascular resistance.
Figure 2 Regression Between PVR and PAC
Polynomial regression displaying the relationship of PVR and PAC in 98 patients
with COPD with PH (blue circles) and without PH (light blue circles). Abbreviations
as in Figure 1. PH ¼ pulmonary hypertension; Wu ¼ Wood units.
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1107wall thickness and PA compliance (r2 ¼ 0.3; p < 0.01) and
PVR (r2 ¼ 0.3; p < 0.01), respectively.
Multiple regression analysis. RV myocardial performance
index, systolic strain, and RV isovolumic acceleration were
dependent variables and age, sex, body mass index, forced
expiratory ventilation percent predicted, PaO2, inspiratory
capacity/total lung capacity ratio, RV wall thickness, PWP,
and mPAP were independent variables in multiple regres-
sion analysis. This resulted in RV wall thickness and mPAP
as independent determinants of RV myocardial performance
index (RV wall thickness: b ¼ 0.492 [95% CI: 0.263 to
0.720; p ¼ 0.000]; mPAP: b ¼ 0.010 [95% CI: 0.006 to0.012; p ¼ 0.000]) and systolic strain (RV wall thickness:
b ¼ 7.600 [95% CI: 1.079 to 14,122; p ¼ 0.023]; mPAP:
b ¼ 0.240 [95% CI: 0.113 to 0.368; p ¼ 0.000]). RV iso-
volumic acceleration was predicted by RV wall thickness
(b ¼ 0.965 [95% CI: 1.827 to 0.103; p ¼ 0.029]) and
PaO2 (b ¼ 0.116 [95% CI: 0.050 to 0.181; p ¼ 0.001]).
Age, sex, and body mass index were nonsigniﬁcant and not
selected by automatic forward selection.
Interobserver and intraobserver variability. Intraclass
correlation coefﬁcients of interobserver variability for RV
acceleration during isovolumic contraction, strain, myocar-
dial performance index, RV basal dimension, and wall
thickness were 0.99 (0.99 to 1.00), 0.94 (0.74 to 0.98), 0.99
(0.95 to 0.99), 0.91 (0.64 to 0.98), and 0.95 (0.79 to 0.98)
and of intraobserver variability were 0.91 (0.70 to 0.98), 0.94
(0.80 to 0.98), 0.99 (0.97 to 0.99), 0.99 (0.98 to 0.99), and
0.97 (0.92 to 0.99), respectively (p < 0.001 for all).Discussion
The present study showed that reduced RV systolic func-
tion, RV hypertrophy, and dilation were present even in
patients with COPD who did not have PH compared with
controls. These ﬁndings suggest that cardiac complications
on the right side start early in the course of the pulmonary
vascular disease, are incremental, and lead to RV impairment
even at subclinical levels of elevated mPAP, PVR, and
reduced PA compliance.
Impact of increased afterload on RV remodeling and
function. One of the key ﬁndings in the present study is the
observation that a small increase in mPAP at rest, even slightly
above the considered normal level of 14.7  4.0 mm Hg (17)
and below 20 mm Hg (18), contributed to a signiﬁcant and
substantial adaptive increase in RV wall thickness and dilation
Table 3 Echocardiographic Data for 98 Patients With COPD With and Without PH and 34 Healthy Controls
Variables
Healthy Controls
(n ¼ 34)
Patients With COPD (n ¼ 98)
p Value
(Analysis of Variance)No PH (n ¼ 72) PH (n ¼ 26)
RV global function
RV myocardial performance index 0.33  0.05 0.50  0.12* 0.67  0.15*y <0.01
RV systolic function
RV basal longitudinal strain (%) 31  4 22  4* 18  3*y <0.01
TDI RV isovolumic acceleration (m/s2) 3.1  0.7 2.0  0.4* 1.6  0.5*y <0.01
TAPSE (mm) 27  3 22  3* 19  4*y <0.01
TDI tricuspid annular displacement (mm) 26  5 22  3* 18  4*y <0.01
RV fractional area change (%) 47  8 39  8* 34  8*y <0.01
RV fractional shortening (%) 50  13 40  14* 38  10* <0.01
TDI tricuspid annular systolic velocity (cm/s) 15.2  3.1 12.8  2.2* 12.8  2.6* <0.01
TDI RV basal systolic velocity (cm/s) 11.5  1.6 9.1  1.1* 8.5  0.7* <0.01
Three-dimensional RV ejection fraction (%) 58  4 50  5* 46  6*y <0.01
RV geometry
RV outﬂow tract wall thickness (mm) 3.5  0.5 5.5  1.0* 6.6  1.1*y <0.01
RV outﬂow tract 1 proximal (cm/m2)z 1.47  0.2 2.00  0.47* 2.09  0.33* <0.01
RV outﬂow tract 2 distal (cm/m2)z 1.24  0.11 1.39  0.18* 1.42  0.19* <0.01
RV hypertrophy (%) 0 42* 92*y <0.01
RV dimension 1 base (cm/m2)z 1.45  0.15 1.95  0.30* 2.13  0.39*y <0.01
RV dimension 2 mid (cm/m2)z 1.15  0.17 1.42  0.31* 1.52  0.34* <0.01
RV dimension 3 base apex (cm/m2)z 4.04  0.29 4.56  0.43* 4.69  0.57* <0.01
Values are mean  SD or %. *Signiﬁcantly different (p < 0.01) from controls. ySigniﬁcantly different (p < 0.01) from no PH. zIndexed for body surface area.
TAPSE ¼ tricuspid annular plane systolic excursion; TDI ¼ tissue Doppler imaging; other abbreviations as in Tables 1 and 2.
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1108and impaired function. The rise in resting mPAP above 25
mmHg is a late marker of the remodeling process, and>50%
of the pulmonary vascular bed is at this point already destroyed
with a pronounced impact on the right ventricle (19).
Although this is a new ﬁnding in patients with COPD, similar
results have been documented in an early phase of patients
prone to developing pulmonary arterial hypertension (20).
A polynomial relationship between PVR and PA compli-
ance was shown, both of which are considered essential for
RV afterload (8) (Fig. 2). Lankhaar et al. previously demon-
strated a similar ﬁnding in patients with PA hypertension (21),
and Friedberg et al. showed a hyperbolic relationship be-
tween RV wall thickness and PA compliance in children (22).
We demonstrated that RV wall thickness was related to both
PVR andPA compliance, which emphasizes the importance of
these 2 indices for the remodeling process of the right ven-
tricle. To the best of our knowledge, we are the ﬁrst to report on
these relationships in patients with COPD.
The no PH group in the present study had a slightly
elevated PVR and substantially reduced PA compliance
compared with healthy controls with reported normal values
of 8.0  0.9 ml/mm Hg (23). Data from a case-control study
of PA stiffness in COPD assessed by cardiac magnetic
resonance imaging have shown a trend toward increased PA
stiffness compared with controls (24). There are, however,
limited data by right heart catheterization, and in general
these studies are small and include severe and very severe
COPD and to a lesser extent mild to moderate COPD (25).
We and others have shown a steeper response in mPAP/
cardiac output slopes by exercise in patients with COPDthan in controls (10,26). Such a temporary increase in RV
afterload during slight exercise, which corresponds to daily
life activities in patients with COPD, could partly in concert
with nocturnal desaturation and a subsequent increase in PA
pressure explain the presence of right heart abnormalities
observed in the present study.
Other mechanisms for RV remodeling and dysfunction.
The dissociation between PH and RV remodeling and
impaired function in the early stages of COPD (mPAP
<20 mmHg) suggests that additive mechanisms to increased
afterload, such as lung hyperinﬂation, systemic inﬂammation,
and endothelial dysfunction, might have a direct and negative
impact on the right ventricle. This may also in part explain
the poor association between RV function and remodeling
and forced expiratory ﬂow per second, indicating that this
important parameter of COPD severity is more connected to
obstruction than to hypoxemia. The strong correlation
between PaO2 and mPAP also reﬂects the important role of
chronic hypoxemia in vascular remodeling; even at early
stages of COPD, there was a slight reduction of PaO2
compared with normal values (Table 4).
The augmented right atrial pressure in COPD-PH is
probably caused by intrinsic impairment of RV function in
concert with the increased afterload leading to diastolic over-
load. Inappropriate treatment with diuretics might increase
this problem. The hypoxemic-induced hyperkinetic circulation
by a cardiac index in the upper normal range, particularly
evident in those with PH but also in those with no PH, may
also play a role in diastolic overload. In addition, the relative
chronic hypercapnia in COPD that leads to HCO3
 and Naþ
Figure 3 RV Functional and Geometric Indices
(A) Comparisons of group mean values (controls, no PH, and PH) of mPAP and tissue Doppler imaging–derived echocardiographic variables of RV systolic function: RV
myocardial index (MPI), RV basal strain, and RV isovolumic acceleration (IVA). (B) Mean body surface area indexed values for basal RV (RVD1) and proximal RV outﬂow tract
dimensions (RVOT1) and RV thickness (RV WT) for the same 3 groups, also in relation to mPAP, are shown. In controls, mPAP was estimated by pulmonary artery–pulsed Doppler
acceleration time, whereby mPAP ¼ 79  (0.45  AcT) (14), in the no PH and PH groups by right heart catheterization. The correlation coefﬁcient to invasive mPAP was 0.88
(p < 0.001) (see Fig. 4). *Signiﬁcantly different from controls. ySigniﬁcantly different from no PH. mPAP ¼ mean pulmonary artery pressure; RV ¼ right ventricular; other
abbreviations as in Figures 1 and 2.
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1109retention at the kidney level, along with the osmotic result of
H2O reabsorption, may contribute to the increased circulating
blood volume and diastolic overload as well (27).
Nine percent of our patients with COPD had diabetes, all
were current or former smokers, many had slightly increased
systemic blood pressure, and mean PWP and the echo
estimated LV ﬁlling pressure in the PH group were in the
upper part of normal limits. Subclinical coronary heart
disease also could not be excluded. Moreover, there was
a slight impairment of LV ejection fraction, although it was
well within normal limits. LV diastolic heart failure with
preserved LV ejection fraction in some of our patients withCOPD can thus not entirely be excluded. On the other
hand, none had large left atrial volumes, PWP of more than
15 mm Hg, or echo estimated LV ﬁlling pressure above 15.
Conversely, LV function can also be inﬂuenced by hyper-
inﬂation (28) (Table 1) and by ventricular interdependency
caused by the increased right ventricle (size and wall thick-
ness) through the common ventricular septum (29).
Echocardiographic indices to assess RV function. The
RV myocardial performance index combines measures of
systolic and diastolic RV function and is thus presumed to
reﬂect global RV function (30). This index has been vali-
dated in patients with PH and has the advantages of good
Figure 4
Correlation Between Invasive mPAP and PAAcT
in COPD
The ﬁgure displays the correlation between invasive measured mPAP and echo-
cardiographic measurements of PAAcT in 98 patients with COPD. PAAcT ¼
pulmonary artery acceleration time.
Hilde et al. JACC Vol. 62, No. 12, 2013
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1110reproducibility, quick calculation, and no need for geometric
models (30). The RV myocardial performance index ﬁnd-
ings in the present study also support results from previous
noninvasive studies (31,32). Longitudinal strain was ob-
tained from the basal RV free wall, which previously has
been reported as more sensitive compared with mid or apical
levels in COPD (33). In a comparable study by Park et al.
(34), patients with COPD who had PH and RV hyper-
trophy had basal RV free wall strain of 13%. In our PH
group, we had a similar RV wall thickness but an RV strain
value of 18%. The discrepancy in strain is probably due to
lower overall RV function in the group from Park et al (34).Table 4
Invasive Hemodynamics and Echocardiog
in Those With No PH Subdivided Into 2 G
Mean PAP 21 to 24 mm Hg (Borderline)
Variable Controls (n
Right heart catheterization hemodynamics
Mean PAP (mm Hg)
Pulmonary wedge pressure (mm Hg)
Pulmonary vascular resistance (Wood units)
Pulmonary artery compliance (ml/mm Hg)
Cardiac output (l/min)
PaO2 (kPa)y
Echocardiography
RV myocardial performance index 0.33  0
RV isovolumic acceleration (cm/s2) 3.1  0
RV basal strain (%) 31  4
RV outﬂow tract wall thickness (mm) 3.5  0
RVD1 dimension (cm/m2) 1.5  0
RV outﬂow tract 1 dimension (cm/m2) 1.5  0
Values are mean  SD. *Signiﬁcantly different (p < 0.01) between borderline
different (p < 0.01) between normal and borderline versus controls.
Abbreviations as in Tables 1 and 2.RV isovolumic acceleration, TDI strain from the basal RV
free wall, and RV myocardial performance index were the 3 of
10 indices that best could discriminate between healthy controls,
patients with COPD without PH, and patients with COPD
who had PH. However, by applying 2 SDs in the group of
controls, only strain and RV myocardial performance index
could separate healthy controls from those with COPDwithout
PH. The cardiologist should therefore consider reduced RV
function in these patients when the RVmyocardial performance
index and basal RV strain are above 0.43 and below 23%,
respectively. We also consider that our results emphasize more
frequent use of echocardiography in the evaluation of RV
function in COPD, not only because it is inexpensive and
noninvasive, but also because it provides additional information
as compared with invasive right heart catheterization.
Study limitations. Our control group did not undergo
invasive hemodynamic measurements for ethical reasons.
However, noninvasively estimated mPAP was normal and
consistent with reported mPAP values of healthy subjects
older than 50 years of age (17).
Echocardiography and right heart catheterization were
not performed simultaneously. However, because the echo-
cardiographic examinations were comprehensive and there
was a risk of suboptimal patient positioning during these
recordings, we decided to perform the 2 examinations
separately in the patients, which also provided similar
conditions as the controls.
The duration of RV isovolumic acceleration is short (20
to 40 ms). The median frame rate was 175 frames/s (i.e., data
are acquired every 5 to 6 ms), which may result in a slight
underestimation of peak velocity. The acceleration time of RV
isovolumic acceleration is also angle dependent, and difﬁ-
culties in beam alignment could represent a source of error.
An important issue of the present study was to evaluate
the impact of pre-capillary pulmonary vascular alterationsraphic Functional and Geometry Measurements
roups: Mean PAP 20 mm Hg (Normal) and
¼ 34) Normal (n ¼ 51) Borderline (n ¼ 21)
17  2 23  1*
8  4 10  4*
1.8  0.7 2.4  1.1*
4.3  1.3 3.7  1.4
5.2  1.0 5.2  0.9
9.9  1.2 9.5  1.1
.05 0.50  0.13z 0.48  0.08z
.7 2.1  0.4z 1.9  0.3z
22  4z 21  3z
.5 5.4  1.0z 5.8  0.9z
.2 1.9  0.3z 2.0  0.4z
.2 1.9  0.04z 2.1  0.6z
and normal. yStandard conversion; 1 kPa ¼ 7.501 mm Hg. zSigniﬁcantly
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1111on RV function. Our ﬁndings are thus not generalizable to
all patients with COPD.
Conclusions
The present study has shown, in a group of outpatients with
COPD who had the post-capillary impact thoroughly excluded,
impaired RV systolic function along with RV hypertrophy and
dilation. The majority of these patients did not have PH, which
emphasizes that even minor elevations in mPAP have impor-
tant consequences for RV function and structure; however, the
dissociation to PH at early stages of COPD indicates other
mechanisms as well. RV isovolumic acceleration, RV basal
strain, and RV myocardial performance index seem to be the
echocardiographic indices that best can identify patients with
COPD who have subclinical reduced RV function.
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